SLC7A11 and hepatocellular carcinoma: This study is the first to reveal the EOGT-HEY1-SLC7A11 regulatory axis, clarifying the role of EOGT in inhibiting ferroptosis and promoting tumor proliferation in HCC, providing new potential therapeutic targets and strategies for the treatment of HCC (98).